Open Flow Microperfusion
Instruments and methods for the measurement of pharmacokinetics and pharmacodynamics in different tissues.
Open Flow Microperfusion (OFM) - Technology
OFM enables the continuous collection of interstitial fluid in (pre)clinical studies for drug development and biomarker research.
OFM is a patented, catheter-based and membrane-free method for the continuous collection of minute amounts of interstitial fluid from various tissues. It enables access to the entire biochemical information of the interstitium and thus opens up completely new perspectives in preclinical and clinical (pharmacological) research and drug testing. The membrane-free OFM catheters have an exchange surface without a diffusion barrier, so that sampling is not restricted by the size, lipophilicity of substances or protein binding effects.
- Applications: pharmacokinetics, pharmacodynamics, bioequivalence, bioavailability, dose finding, drug metabolism
- Substances: active ingredients (low molecular weight to antibody-based; fat and water-soluble), endogenous substances (substances ranging from small molecules to cells)
- Preclinical models: pig, rat, mouse
- Tissue: skin, mucous membrane, brain, muscle, fatty tissue, lymph, cancer
Preclinical Research
We manufacture OFM materials for preclinical studies and distribute them worldwide.
- Products: information on the various OFM products, our product catalog, application videos, FAQs or the instructions for use can be found here
- Sales regions and countries: Europe, North, Central and South America, Japan, China, South Korea, Hong Kong, Singapore, Australia, Russia, Israel, India. Write us and we will put you in touch with your local sales partner.
Clinical Research
- OFM-Materialien für klinische Studien sind als Medizinprodukte zugelassen und CE zertifiziert.
- Applications: skin, muscle, fatty tissue
Research groups
Downloads
Shareholdings & Funding
Das sagen unsere Kunden
More Products and Services
Fast and efficient PK-based bioequivalence studies for topical generics
Unique de-risking and proof-of-mechanism studies for dermal active ingredients
Specialized methods for analyses and testing for preclincial and clinical studies (GLP and non-GLP).
Comprehensive and compliant data management and biostatistics for clinical trials
We test drug release in a fast and reliable way using IVRT based on vertical diffusion cells and synthetic membranes.
We perform untargeted and targeted metabolomics studies to quantify metabolites to investigate metabolic processes and identify biomarkers.
The digital checklist and cross-professional process documentation for surgical procedures.
CDS-BARS module for patient-centered, cross-professional, interdisciplinary collaboration and documentation on acute geriatric wards
We offer extensive, professional support in reporting and publishing the results of your preclinical and clinical studies.
aOFM can be used to monitor local drug distribution and biomarkers in subcutaneous adipose tissue.
